Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)

SIMPLE SUMMARY: Immune checkpoint inhibitors have received considerable interest because of their ability to generate durable response in many intractable malignant solid tumors. The therapeutic results of immune checkpoint inhibitors in recurrent or advanced uterine cervical cancer, which associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Min Chul, Kim, Yong-Man, Lee, Jeong-Won, Lee, Yong Jae, Suh, Dong Hoon, Lee, Sung Jong, Lee, Taek Sang, Lee, Maria, Park, Dong Choon, Kim, Min Kyu, Lee, Jong-Min, Shim, Seung-Hyuk, Jeon, Seob, Min, Kyung Jin, Kim, Mi Kyung, Kim, Bo Wook, Park, Jeong Yeol, Kim, Byoung-Gie, Kim, Dae Yeon, Kim, Moon-Hong, Kim, Hyun-Soo, Lee, Jung-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693862/
https://www.ncbi.nlm.nih.gov/pubmed/33138190
http://dx.doi.org/10.3390/cancers12113188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693862/
https://www.ncbi.nlm.nih.gov/pubmed/33138190
http://dx.doi.org/10.3390/cancers12113188

Ejemplares similares